3 studies found for:    18263931 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
Condition: STEMI
Interventions: Genetic: Point-of-Care Genetic Testing;   Drug: Prasugrel
2 Completed ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
Conditions: Stable Coronary Artery Disease;   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
Intervention: Genetic: Point-of-care genetic screening with subsequent prasugrel administration to CYP2C19*2 carriers
3 Unknown  Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition
Conditions: Unstable Angina;   NSTEMI
Interventions: Drug: comparison of different dosage of clopidogrel;   Drug: doubled therapy

Indicates status has not been verified in more than two years